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This study aimed to evaluate the quality of life of female gynecological cancer patients 
submitted to antineoplastic chemotherapy Between August 2007 and April 2009, 50 patients 
who were undergoing chemotherapy at an outpatient chemotherapy unit in Uberaba – MG 
were interviewed, by applying the instrument of evaluation of Quality of Life of the World 
Health Organization, WHOQOL-BREF. The results showed that the domain most affected 
was the Physical and the more preserved, the Social, with the mean of the general quality 
of life above the means obtained in other studies. All domains correlated significantly with 
the general quality of life. It was evident then that the quality of life of these women is 
satisfactory, however it is suggested that the domains with lower scores be the targets of 
more accurate observations during multi-professional interventions in order to provide a 
better quality of life during the chemotherapy treatment.
Descriptors: Oncologic Nursing; Quality of Life; Drug Therapy; Neoplasms.
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Avaliação da qualidade de vida de portadoras de câncer ginecológico, 
submetidas à quimioterapia antineoplásica
Este estudo teve como objetivo avaliar a qualidade de vida de mulheres portadoras de 
câncer ginecológico, submetidas à quimioterapia antineoplásica. Foram entrevistadas 50 
pacientes, no período de agosto de 2007 a abril de 2009, que estavam em tratamento 
quimioterápico em um ambulatório de quimioterapia de Uberaba, MG, mediante aplicação 
do instrumento de avaliação de Qualidade de Vida da Organização Mundial da Saúde-
WHOQOL-bref. Os resultados apontaram que o domínio mais comprometido foi o físico 
e o mais preservado, o social, sendo que a qualidade de vida geral obteve média acima 
da obtida em outros estudos. Todos os domínios correlacionaram-se significativamente 
com a qualidade de vida geral. Pode-se evidenciar, então, que a qualidade de vida dessas 
mulheres é satisfatória; entretanto, sugere-se que os domínios com escores mais baixos 
sejam alvo de observações mais acuradas, durante as intervenções multiprofissionais, a 
fim de se proporcionar melhor qualidade de vida durante o tratamento quimioterápico.
Descritores: Enfermagem Oncológica; Qualidade de Vida; Quimioterapia; Neoplasias.
Evaluación de la calidad de vida de portadoras de cáncer ginecológico, 
sometidas a quimioterapia antineoplásica
Este estudio tuvo como objetivo evaluar la calidad de vida de mujeres portadoras de 
cáncer ginecológico sometidas a quimioterapia antineoplásica. Fueron entrevistadas 50 
pacientes en el período de agosto de 2007 a abril de 2009 que estaban en tratamiento 
quimioterapéutico en un ambulatorio de quimioterapia de Uberaba–MG, mediante la 
aplicación del instrumento de evaluación de Calidad de Vida de la Organización Mundial 
de la Salud-WHOQOL-bref. Los resultados apuntaron que el dominio más comprometido 
fue el físico y el más preservado, el social, siendo que la calidad de vida general obtuvo un 
promedio superior al obtenido en otros estudios. Todos los dominios se correlacionaron 
significativamente con la calidad de vida general. Se puede evidenciar, entonces, que 
la calidad de vida de esas mujeres fue satisfactoria; sin embargo se sugiere que los 
dominios con puntajes más bajos sean examinados con observaciones más exactas 
durante las intervenciones multiprofesionales, a fin de proporcionar una mejor calidad 
de vida durante el tratamiento quimioterapéutico.
Descriptores: Enfermería Oncológica; Calidad de Vida; Quimioterapia; Neoplasias.
Introduction
Cancer is incident in the population in an 
overwhelming way, due to the demographic transition we 
are experiencing today, as well as the growing exposure 
of the population to carcinogens in the environment. 
Gynecologic cancer, especially breast and cervical 
cancer remain the most common among women, with 
estimates, for Brazil, of more than 70,000 new cases for 
the year 2010(1).
The use of antineoplastic chemotherapy as a 
systemic therapeutic resource against cancer, is proving 
to be ever more promising, given the purification of drugs, 
and the development of administration protocols that 
allow the concurrent use of more than one compound, as 
well as the reversing of side effects by applying rescue, 
symptomatic and protective therapy(1-3).
In this context, nursing has been participating 
in cancer control initiatives and has been consistently 
assuming care actions in the administration of various 
treatments for disease, particularly antineoplastic 
chemotherapy(3). There is an increasing emphasis 
on evaluating the quality of life of people treated for 
cancer, due to factors such as advances in the detection 
851
www.eerp.usp.br/rlae
Jorge LLR, Silva SR.
and treatment of the disease, more optimistic social 
attitudes, the increase in the number of survivors, the 
concern with the autonomy and rights of patients, the 
role of psychosocial factors, the extent of survival, 
among others(4-5).
The World Health Organization (WHO) defines 
quality of life as “an individual’s perception of his/her 
position in life in the context of the culture and value 
systems in which he/she lives, and in relation to his/her 
goals, expectations, standards and concerns”(4). However, 
to assess or measure quality of life is a complex task, 
given the subjective nature of the subject. Therefore, 
the proposed use of an instrument for assessing quality 
of life, valid for all human groups, by the WHO, aims 
to homogenize the concept and to provide professionals 
with a technical-scientific, standardized and consistent 
tool(6). The instrument proposed by the WHO evaluates 
quality of life in domains denominated as Physical, 
Psychological, Social relationships and Environment 
that interpret the perception that the individuals have 
of themselves and their surroundings, as favorable or 
not(6).
In our professional pathway we have been keen 
to develop studies and practices related to immediate 
and delayed side effects of antineoplastic chemotherapy, 
and to assess the impact of this treatment in the lives 
of patients with gynecologic cancer. There is a need, 
however, for a thorough and systematic study, based on 
a consistent and consolidated instrument for evaluating 
the quality of life of patients during treatment, in order 
to respond ever more effectively and efficiently to their 
needs, considering, the integral aspect of the individual, 
aiming for a holistic therapeutic proposal.
Our proposal is justified because it contributes to the 
construction of knowledge of oncology nursing related 
to the quality of life of those who undergo aggressive 
treatment for cancer, and has sought to understand the 
life situations of people with cancer(7).
This study therefore aims to evaluate the quality 
of life of patients with gynecologic cancer undergoing 
antineoplastic chemotherapy, by applying the instrument 
proposed by the WHO, the WHOQOL-BREF.
Methods
This descriptive and cross-sectional study was 
developed in the Chemotherapy Centre of the Clinical 
Hospital of the Federal University of Triangulo Mineiro 
(UFTM), which aims for care, teaching and research. 
The study population consisted of all patients with 
gynecological cancer over 18 years of age, undergoing 
antineoplastic chemotherapy, who agreed to participate 
in the study by understanding and signing the Terms of 
Clarification and Consent respectively, from August 2007 
to April 2009. An opportune moment for the interview 
was understood to be 10-14 days after administration of 
the third cycle of chemotherapy. This moment was chosen 
for the application of the data collection instrument 
because this is a moment for which all patients would 
pass, as some treatments are composed of three, four, 
six or more cycles, being a minimum of three.
Data collection was performed in two stages: firstly, 
all patients undergoing chemotherapy and residents of 
Uberaba were interviewed, with the interviews conducted 
during pre-scheduled home visit (August 2007 to July 
2008); secondly, patients that were non-residents of 
Uberaba were included in the study, and data collection 
began to be performed at Chemotherapy Central during 
their treatment (from July 2008 to April 2009). This 
extension to the study was justified by the observation 
that data collection could be performed during treatment 
and that with this a larger number of patients could be 
addressed.
In the period described, there were 71 patients 
undergoing chemotherapy at the research site, two 
refused to participate in the study, one had no cognitive 
conditions to answer the questionnaire and 18 were 
excluded, in the first stage of data collection, due to not 
residing in Uberaba, totaling, therefore, a population of 
50 individuals.
Data were collected in private, the interviews being 
carried out in the room where the patients received 
chemotherapy. Due to the infusion often lasting several 
hours and, according to the experience of the researchers 
in the service and the staff of the site, this being the 
best place for the interview. Although most of the time, 
a family member was present at the venue, they were 
asked not to intervene. Before starting the interviews, 
all were once again informed of the research objectives, 
the confidentiality of information obtained, as well as 
the mode of application and the destination of the data, 
being asked to sign a terms of consent form.
To collect the data, the WHOQOL-BREF was used, 
a shortened version in Portuguese of the Quality of Life 
Assessment Instrument of the WHO, validated for the 
Brazilian culture(6). This instrument consists of two parts, 
the first being an information form about the Respondent, 
which is designed to collect socio-demographic and health 
data of the subjects. The second part, about quality of life 
itself, is composed of 26 questions, two on general quality 
of life and the remaining 24 representing four domains 
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and their facets that make up the original instrument, 
of Physical, Psychological, Social relationships and 
Environment domains.
The answers to all questions of the WHOQOL-
BREF are obtained through a Likert type scale of five 
points, in which scores can range from 1 to 5. Both the 
domains and the general quality of life are measured in 
the positive direction, i.e. higher scores denote higher 
quality of life. To calculate the domain scores, we used 
the syntax provided by the WHOQOL Group for use in 
the software program SPSS (Statistical Package for 
Social Science). With it, the program can check, recode 
and establish domain and questions of general quality 
of life scores.
For data analysis, descriptive statistics (frequency, 
proportion, means of position and dispersion) and 
the Pearson’s coefficient were used to evaluate the 
correlation of each domain with the general quality of 
life. The value of p<0.05 (α= 5.0%) was adopted as the 
critical level.
To develop the study, advice and consent was 
sought and obtained from the Human Research Ethics 
Committee of the Institution (protocol No. 709/2006).
Results
Fifty patients were interviewed, 12 of whom 
(24.0%) were between 20 and 39 years of age, 24 
(48.0%) between 40 and 59 years, and 14 (28.0%) 
aged 60 years or over, with a mean age of 48.4 (± 
12.0) years. Regarding educational level, three (6.0%) 
were illiterate, 31 (62.0%) had incomplete primary 
education, four (8.0%) complete primary education, 
one (2.0%) incomplete high school, nine (18.0%) 
completed high school, one (2.0%) incomplete higher 
education and one (2.0%) complete higher education. 
In relation to marital status, 11 (22.0%) were single, 
26 (52.0%) married, four (8.0%) were cohabiting, 
two (4.0%) separated, two (4, 0%) divorced and five 
(10.0%) widowed.
Regarding the type of cancer, 29 (58.0%) were 
suffering from breast cancer, 11 (22.0%) from cervical 
cancer, eight (16.0%) from ovarian cancer, one (2, 0%) 
from endometrial cancer and one (2.0%) from vaginal 
cancer. Questioned regarding self-rated health, 20 
patients (40.0%) classified it as “very good” or “good”, 
16 (32.0%) as “neither good nor bad” and 14 (28.0 %) 
as “very bad” or “weak”. In relation to satisfaction with 
health, 27 (54.0%) were “satisfied”, 14 (28.0%) “neither 
satisfied nor dissatisfied” and nine (18%) “dissatisfied” 
or “very dissatisfied”.
Regarding treatment protocols, 20 patients 
(40.0%) were using epirubicin and cyclophosphamide 
(EC), 11 (22.0%) used cisplatin, etoposide and 
bleomycin (PEB), nine (18%) paclitaxel and ten (20%) 
were using other protocols. Frequency distributions of 
the protocols used with the scores obtained for each of 
these are described in Table 1.
Treatment Protocol Nº of Patients % Score
Epirubicin and cyclophosphamide 20 40.0 63.7
Cisplatin, etoposide and bleomycin 11 22.0 75.0
Paclitaxel 09 18.0 61.1
Cisplatin, epirubicin and 
cyclophosphamide 02 6.0 43.8
Cisplatin and cyclophosphamide 03 6.0 33.3
Paclitaxel and cyclophosphamide 02 4.0 75.0
Cisplatin and 5-fluorouracil 01 2.0 75.0
Cyclophosphamide, methotrexate 
and 5-fluorouracil 01 2.0 62.5
5-fluorouracil, epirubicin and 
cyclophosphamide 01 2.0 62.5
Table 1 - Frequency of treatment protocols and scores 
obtained using the WHOQOL-BREF for patients in 
outpatient chemotherapy (n = 50). Uberaba, 2009
The results obtained in the evaluation of quality 
of life with the WHOQOL-BREF are shown in Table 2. It 
was observed that the most compromised domains were 
the Physical and Environment domains, and the most 
preserved, the Social domain.
Table 2 - Scores obtained using the WHOQOL-BREF of patients in outpatient chemotherapy (n = 50). Uberaba, 
2009
Domains Mean Standard deviation Median Minimum Maximum
Physical 56.0 13.5 57.1 21.4 85.7
Psychological 62.6 12.3 62.5 16.7 83.3
Social 71.0 15.6 75.0 16.7 100.0
Environment 58.1 12.6 56.2 31.2 93.7
General quality of life 68.6 16.8 75.0 12.5 100.0
853
www.eerp.usp.br/rlae
Jorge LLR, Silva SR.
All domains correlated positively and significantly 
with the general quality of life, the Psychological domain 
with a strong magnitude, and the other with moderate 
magnitude, as can be observed in Table 3.
Domains and General quality of life
Domains
Physical Psychological Social Environment
General quality of life 0.55* 0.67* 0.40* 0.41*
Table 3 - Correlation between the domains of WHOQOL-BREF and of these with the Quality of Life of patients in 
outpatient chemotherapy (n = 50). Uberaba, 2009
*p<0.05
Discussion
The data analysis allows the comprehension that 
the age group of highest incidence of gynecological 
cancers is over 40 years of age, which is consistent 
with information provided by the INCA - National 
Cancer Institute. This highlights the importance of 
screening this population with preventive examinations 
and guidance regarding lifestyle, prevention and early 
detection of cancer in the age group 20-49 years(8).
Breast cancer stood out as the most common 
neoplasia among women, followed by cervical cancer, 
supporting the literature. According to the INCA, breast 
cancer stands out as the most frequent in the female 
population of the Southeast of Brazil, with an estimate 
for 2010 of 65 new cases for every 100,000 women. 
Without considering non-melanoma skin tumors, this 
type of cancer is also the most frequent among women 
from the South (64/100,000), Midwest (38/100,000) 
and Northeast (30/100,000), whereas in the North it 
is the second most prevalent (17 per 100,000)(1-2,4). 
However, cervical cancer is the second most frequent 
among the Brazilian female population and represents 
one of the most frequent causes of death in the female 
population in Latin America, where incidence rates are 
among the highest in the world(9).
Regarding self-rated health, most of the 
interviewees rated it as very good or good and 
considered that they are satisfied with it. This result 
indicates that, in view of the prospect of progress of 
a chronic disease, they are satisfied with the moment 
they are experiencing.
With regard to quality of life, it was observed 
that the Physical domain was the most compromised 
(score 56.0). This fact can be explained by the toxicity 
of chemotherapy drugs administered, in relation to 
cellular non-specificity, which can generate effects such 
as pain, fatigue, nausea and vomiting, and additionally 
anorexia, hampering clients in their daily activities 
and thus reducing their quality of life(3,10). Thus, this 
should be investigated and actions proposed to more 
effectively control these effects.
The second most compromised domain was 
the Environment (score 58.1), indicating that these 
clients consider themselves to have some difficulties 
related to the conditions of where they live, security, 
transportation, economic conditions and opportunities 
for recreation and leisure. Studies show that leisure is 
altered after breast cancer, especially in patients with 
lymphedema, because they feel social discomfort due 
to the increase in size of the limb and there is also 
decrease in the intensity, quantity and time devoted 
to activities previously practiced such as sunbathing, 
gardening and physical activities. Moreover, many 
women leave or diminish their professional work, which 
ultimately affects their family financial condition(11-12). 
To help women find alternative leisure opportunities, 
and inform them as to their rights as women with 
cancer are ways to minimize the environmental impact 
in their quality of life.
Due to the diverse changes occurring in the family 
routine, and the impact caused by the diagnosis of cancer 
and chemotherapy, the Psychological domain was also 
affected, although to a lesser extent, in the quality of life 
of these women. The occurrence of treatment in their 
life is experienced in a particular way for each woman. 
Furthermore, the affected woman’s age also influences 
their adaptation and the biopsychosocial sequelae caused 
by cancer. Depending on the life cycle of the women, 
their activities and plans, such as in relation to family 
and work, are fully affected, especially the femininity and 
self-esteem in young women. However, anxieties, fears, 
worries and apprehension are feelings that accompany 
all of these clients, from diagnosis until the end of cancer 
treatment. This highlights the need for psychological 
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support offered by the whole multidisciplinary team and 
for therapeutics with psychologists, in addition to support 
from the family and partner, which has an important role 
in the adaptation of these patients(10-11,13).
Although studies show that gynecological cancer 
and antineoplastic chemotherapy may obstruct personal 
relationships, given the greater reliance on others to 
perform various tasks and/or the possible changes in 
physical appearance or body self-image, the Social 
domain was the least compromised in this study(9-10), 
followed by the Psychological domain. In a similar study, 
with ostomy patients suffering from colorectal cancer, it 
was also found that the most compromised domain was 
the Physical, and the Social the least compromised(14). 
It was observed that even with the changes imposed by 
the disease and treatment, these women are satisfied 
with their personal relationships, their sexual activities 
and, especially, with the support they receive from 
relatives and friends, thus contributing significantly to 
coping well with this process.
Regarding the general quality of life, it was found 
that the score obtained in this study, in addition to 
corresponding to a good quality of life was also superior 
to those obtained in other studies(13-15).
In relation to the influence of the domains on the 
general quality of life, it was found that the Psychological 
domain had the highest correlation, followed by the 
Physical domain, in this population. The Environment 
and Social domains were those with lower correlations, 
although significant. These findings contribute in part 
to understanding the high values found for the general 
quality of life in our study group, since the Psychological 
domain had the second highest score and Environment 
the lowest.
This study contributes to others related to the 
evaluation of quality of life of patients with degenerative-
chronic diseases(16) in general, more specifically in 
oncology, which have shown to be effective tools for 
oncology nursing(17), for contributing to the construction 
of scientific knowledge and the development of skills in 
the area of oncology.
Conclusions
Based on data collected and analyzed, it can be 
said that the perception of quality of life of the women 
monitored in the development of this study is satisfactory 
since, due to the recognition of the seriousness of the 
prognosis, they consider it positive that their physical 
and psychological capacities, their social relationships 
and their environment were not affected as they 
believed they would be, thus enabling the performance 
of their practical activities in daily life.
This study also concluded that the domains 
with lower scores should be the subjects of more 
accurate observation and more efficient and effective 
intervention in order to provide a better quality of life 
during chemotherapy.
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